Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling

Ana Quaglino, Carolina Schere-Levy, Leonardo Romorini, Roberto P Meiss, Edith C Kordon

Correlation between CpG methylation profiles and hormone receptor status in breast cancers

Weiwei Feng, Lanlan Shen, Sijin Wen, Daniel G Rosen, Jaroslav Jelinek, Xin Hu, Shaoyi Huan, Miao Huang, Jinsong Liu, Aysegul A Sahin, Kelly K Hunt, Robert C Bast, Yu Shen, Jean-Pierre J Issa, Yinhua Yu

Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?

Christine Fillmore, Charlotte Kuperwasser

No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort

Martijn Verheus, Petra HM Peeters, Paulus AH van Noord, Yvonne T van der Schouw, Diederick E Grobbee, Carla H van Gils

Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients

Javier Silva, Vanesa García, José M García, Cristina Pe？a, Gemma Domínguez, Raquel Díaz, Yolanda Lorenzo, Alicia Hurtado, Antonio Sánchez, Félix Bonilla

Short-term presurgical treatment for all?

Mitch Dowsett, Janine Salter, Margaret Hills, Simone Detre, Roger A'Hern, Ian E Smith

Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004

Theresa HM Keegan, Ellen T Chang, Esther M John, Pamela L Horn-Ross, Margaret R Wrensch, Sally L Glaser, Christina A Clarke

Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis!

Steven M Anderson, Michael C Rudolph, James L McManaman, Margaret C Neville

Involvement of α6β4 integrin in the mechanisms that regulate breast cancer progression

Giulia Bon, Valentina Folgiero, Selene Di Carlo, Ada Sacchi, Rita Falcioni

BP1 transcriptionally activates bcl-2 and inhibits TNFα-induced cell death in MCF7 breast cancer cells

Holly S Stevenson, Sidney W Fu, Joseph J Pinzone, Jinguen Rheey, Samuel J Simmens, Patricia E Berg

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification

Anne Cayre, Florence Mishellany, Nicole Lagarde, Frédérique Penault-Llorca

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

Bas Kreike, Marieke van Kouwenhove, Hugo Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink, Marc J van de Vijver

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E Hynes

A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

Heidi Schwarzenbach, Volkmar Müller, Cord Beeger, Miriam Gottberg, Nicole Stahmann, Klaus Pantel

Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism

Sailesh Gochhait, Syed Bukhari, Narendra Bairwa, Shivani Vadhera, Katayoon Darvishi, Mohammad Raish, Pawan Gupta, Syed Husain, Rameshwar NK Bamezai

Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study

Yngve Bremnes, Giske Ursin, Nils Bjurstam, Inger T Gram

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study

Marc van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault-Llorca, Josef Rüschoff

Mammary stem cell number as a determinate of breast cancer risk

Christophe Ginestier, Max S Wicha

Amping up estrogen receptors in breast cancer

Amy M Fowler, Elaine T Alarid

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

Louise R Howe

Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage

Heather L LaMarca, Jeffrey M Rosen

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

David G DeNardo, Lisa M Coussens

Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis

David L Mack, Corinne A Boulanger, Robert Callahan, Gilbert H Smith

Breast cancer is a promising target for vaccination using cancer-testis antigens known to elicit immune responses

Mark Taylor, Louise M Bolton, Peter Johnson, Tim Elliott, Nick Murray

Analysis of the cellular centrosome in fine-needle aspirations of the breast

Hui-qin Guo, Meixia Gao, Jinfang Ma, Ting Xiao, Lin-lin Zhao, Yanning Gao, Qin-jing Pan

Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer

Yun Liu, Massimo Bellomi, Giovanna Gatti, Xuejun Ping

The continuing search for cancer-causing somatic mutations

Gillian L Dalgliesh, P Andrew Futreal

Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study

Marjorie L McCullough, Victoria L Stevens, William R Diver, Heather S Feigelson, Carmen Rodriguez, Robin M Bostick, Michael J Thun, Eugenia E Calle

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ

Martin G？tte, Christian Kersting, Isabel Radke, Ludwig Kiesel, Pia Wülfing

Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas

Stephen J Chanock, Laurie Burdett, Meredith Yeager, Victor Llaca, Anita Langer？d, Shafaq Presswalla, Rolf Kaaresen, Robert L Strausberg, Daniela S Gerhard, Vessela Kristensen, Charles M Perou, Anne-Lise B？rresen-Dale

Oestrogen receptor negative breast cancers exhibit high cytokine content

Carine Chavey, Frédéric Bibeau, Sophie Gourgou-Bourgade, Sandrine Burlinchon, Florence Boissière, Daniel Laune, Sylvie Roques, Gwendal Lazennec

Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity

Gillian E Stillfried, Darren N Saunders, Marie Ranson

Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study

Rulla M Tamimi, David G Cox, Peter Kraft, Michael N Pollak, Christopher A Haiman, Iona Cheng, Matthew L Freedman, Susan E Hankinson, David J Hunter, Graham A Colditz

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family

Meng-Lay Lin, Jae-Hyun Park, Toshihiko Nishidate, Yusuke Nakamura, Toyomasa Katagiri

Benefits of complementary therapies

Caroline Hoffman

Decision making in local therapy for breast cancer

Monica Morrow

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

Laura G Fulford, Jorge S Reis-Filho, Ken Ryder, Chris Jones, Cheryl E Gillett, Andrew Hanby, Douglas Easton, Sunil R Lakhani

A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study

David G Cox, Julie Buring, Susan E Hankinson, David J Hunter

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer

Alexandra F Leary, Bhawna Sirohi, Stephen RD Johnston

Breast cancer risk-assessment models

D Gareth R Evans, Anthony Howell

P-cadherin expression in breast cancer: a review

Joana Paredes, Ana Correia, Ana Ribeiro, André Albergaria, Fernanda Milanezi, Fernando C Schmitt

Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells

Cheng Jiang, Junming Guo, Zhe Wang, Bingxiu Xiao, Hyo-Jung Lee, Eun-Ok Lee, Sung-Hoon Kim, Junxuan Lu

Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

Petra EA Huijts, Maaike PG Vreeswijk, Karin HG Kroeze-Jansema, Catharina E Jacobi, Caroline Seynaeve, Elly MM Krol-Warmerdam, Pauline M Wijers-Koster, Jannet C Blom, Karen A Pooley, Jan GM Klijn, Rob AEM Tollenaar, Peter Devilee, Christi J van Asperen

Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts

Di Chen, Kristin R Landis-Piwowar, Marina S Chen, Q Ping Dou

International Web-based consultation on priorities for translational breast cancer research

Mitch Dowsett, Aron Goldhirsch, Daniel F Hayes, Hans-Joerg Senn, William Wood, Giuseppe Viale

Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer?

April AN Rose, Peter M Siegel

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers

Christina Yau, Vita Fedele, Ritu Roydasgupta, Jane Fridlyand, Alan Hubbard, Joe W Gray, Karen Chew, Shanaz H Dairkee, Dan H Moore, Francesco Schittulli, Stefania Tommasi, Angelo Paradiso, Donna G Albertson, Christopher C Benz

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer

Erica L Mayer, Lisa A Carey, Harold J Burstein

Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?

Javier A Menendez, Ruth Lupu

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705